Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
04 April 1994Website:
http://www.prophaselabs.comNext earnings report:
09 August 2024Last dividends:
24 May 2022Next dividends:
N/APrice
after hours | Tue, 02 Jul 2024 23:28:25 GMTAnalysts recommendations
Institutional Ownership
PRPH Latest News
ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q3 2023 Earnings Conference Call November 9, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Partners Yi Chen - H.C. Wainwright Hunter Diamond - Diamond Equity Dennis Waldman - Barrett Productions Operator Good day and welcome the ProPhase Labs Incorporated Third Quarter 2023 Financial Results and Corporate Update.
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2023 Earnings Conference Call August 10, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Conference Call Participants Adam Waldo - Lismore Partners Dennis Waldman - Barrett Productions Yi Chen - H.C. Wainwright Operator Good day, and welcome to the ProPhase Labs Second Quarter 2023 Financial Results and Corporate Update.
Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a conference call at 11:00 AM ET, Thursday, August 10, 2023, to provide an update on corporate developments and review financial results. Following management's formal remarks, there will be a question-and-answer session.
GARDEN CITY, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, August 10, 2023, at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2023 and provide a business update. A press release detailing these results will be issued prior to the call.
ProPhase Labs thrived in the Covid era and then wisely used the gains to invest in new testing capabilities including whole genome sequencing and a new esophageal cancer test. The capabilities will allow PRPH to greatly increase its currently addressable market, and, if all goes well, within a year and a half revenues should start expanding precipitously. PRPH's finances and operational experience should enable it to get to the developmental finish line without needing to execute any dilutive financings.
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
What type of business is ProPhase Labs?
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
What sector is ProPhase Labs in?
ProPhase Labs is in the Healthcare sector
What industry is ProPhase Labs in?
ProPhase Labs is in the Diagnostics & Research industry
What country is ProPhase Labs from?
ProPhase Labs is headquartered in United States
When did ProPhase Labs go public?
ProPhase Labs initial public offering (IPO) was on 04 April 1994
What is ProPhase Labs website?
https://www.prophaselabs.com
Is ProPhase Labs in the S&P 500?
No, ProPhase Labs is not included in the S&P 500 index
Is ProPhase Labs in the NASDAQ 100?
No, ProPhase Labs is not included in the NASDAQ 100 index
Is ProPhase Labs in the Dow Jones?
No, ProPhase Labs is not included in the Dow Jones index
When does ProPhase Labs report earnings?
The next expected earnings date for ProPhase Labs is 09 August 2024